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Prostatic Neuroendocrine Cells Have a Unique 
Keratin Expression Pattern and Do Not 
Express Bcl-2
Cell Kinetic Features of Neuroendocrine Cells in the Human 
Prostate
Yong Xue,* Albert Verhofstad,1' Wil Lange,1,
Frank Smedts,* Frans Debruyne,*
Jean de la Rosette,* and Jack Schalken*
Prom the Department o f Umlog}& and Pathology,' Ibiiivrsily 
Hospital Nijmegen, Nijmegen, and  tbe Department o f  Pathology;* 
I'unndaiion o f  Collaborating Hospitals in Hast Groningen, 
Winschoten, Tbe Netherlands
Wc investigated the keratin phenotype and bcl-2 im- 
munoreactlvity of neuroendocrine cells in the human 
prostate to determine whether the postmitotic status 
o f  these cells is associated with protection from apo- 
ptosls by bcl-2 protein expression and to elucidate the 
possible cell kinetic relationship between neuroendo­
crine cells and the other epithelial components of the 
prostate. Tissue specimens were selected from pros­
tates of 19 patients harboring normal secretory 
glands (n = 15) and glandular benign prostatic hyper­
plasia (n = 10). Using a novel sequentially selective 
dcstalnlng immunoen/ymatic cytochemlcal tech­
nique we were able to demonstrate the distribution of 
neuroendocrine cells, keratin markers Identifying ei­
ther basal, luminal, or intermediate cells» and the 
bcl-2 protein In single sections. Basal cell keratins 
were expressed In the minority of the neuroendo­
crine cells. In most of the cells, intermediate and 
luminal cell keratins were found and bcl-2 was con­
stantly negative. Our findings indicate that neuroen­
docrine cells and other epithelial cells in the human 
prostate share a common keratin phenotype and 
probably originate from a common epithelial precur­
sor. From the absence of bcl-2 we Infer that the neu­
roendocrine cells have no progenitor cell character­
istics. (AmJ Pathol 1997\ 151:1759-1765)
during puberty, after which their number slowly increases 
during adult life/" NE cells are believed to play an Impor­
tant role in prostate growth and differentiation 3 Previous 
studies have shown that they probably are associated 
with the development of benign prostatic hyperplasia 
(BPH) and an unfavorable clinical outcome in prostate 
carcinoma (PCa).4"6
Although interest in NE cells of the human prostate has 
increased in the last years, our knowledge concerning 
the fundamental characteristics of these cells and their 
relationship with other epithelial cells in the prostate (ie, 
exocrine cells) is still fragmentary and controversial/ 10 
Some authors suggest that they are derived from the 
neural crest, although others adhere to a unitarian theory 
stating that they develop locally from a progenitor stem 
cell common to the other, exocrine, prostatic epithelial 
cells.11 Another subject to be clarified concerns the sta­
tus of NE cells with regard to their susceptibility to apo- 
ptotic cell death. Studies investigating bcl-2 expression 
in a variety of tissues indicate that this protein plays an 
important role in maintaining stem cell status and tissue 
homeostasis by inhibiting apoptotic cell death.n-,,H In the 
human prostate epithelium, bcl-2 is expressed in basal 
cells.1'1,1*’ In a study devoted to PCa with NE differentia­
tion, in two of six cases a proximate relationship between 
NE cells and cells expressing bcl-2 was demonstrated, 
However, this report, based on a limited number of spec­
imens, does not allow decisive conclusions as far as 
bcl-2 expression by NE cells is concerned.,,i
In examining cell kinetic features of NE cells in the 
human prostate, application of immunocytochemical 
techniques can be instrumental. Particularly, antibodies 
against the different types of keratin (K) are helpful as 
they are expressed in specific combinations in various 
types of epithelia and are related to specific levels of 
cellular differentiation.17 IH In previous keratin phenotyp- 
ing studies we were able to distinguish three epithelial
. . .  « v  l - l
The human prostate contains the largest number of neu­
roendocrine (NE) cells of any genitourinary organ,1 At 
birth, NE cells are abundant in the prostate and then 
disappear from the peripheral zone, only to reappear
Accoptad (nr publication Auíjiuit P7, 1 íOí)/,
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cell types in the prostate, ie, basal cells expressing K14 
and K5, luminal cells expressing K18 and K8, and cells, 
called intermediate cells, having keratin features of both 
luminal and basal cells (K5 and K18).20"23 These findings 
seem to support the stem cell model proposed by Isaacs 
and Coffey indicating that in prostatic epithelium there is 
a hierarchical differentiation pathway from basally lo­
cated stem cells to terminal transit cells (columnar lumi­
nal cells) via amplifying cells.2'1 The cells we identified as 
intermediate cells are likely candidates for the amplifying 
cells. To date, the keratin status of NE cells in the prostate 
has not been clarified. One study showed that they con­
tain both K14 and K5,B although another report indicates 
that they are devoid of keratins altogether,7 
Recently, we developed a novel immunoenzymatic ap­
proach enabling the simultaneous detection of two anti­
bodies in formalin-fixed, paraffin-embedded tissues while 
maintaining optimal morphology. This technique enabled 
us to study keratin and bcl-2 expression in single prostate 
NE cells, The aim of this study was to determine the 
immunophenotypic characteristics of NE cells to gain 
insight into the possible cell kinetic relationship between 
NE cells and other components of the prostatic epithe­
lium and also to examine whether the postmitotic status of 
the prostate NE cells is associated with protection from 
apoptosis by bcl-2 protein expression,25
marking the luminal cells in the prostate/"1 2U A MAb to 
bcl-2 (124, Dakopatts) was used to demonstrate bcl-2 
that is supposed to be expressed selectively in cells 
protected from apoptotic cell death.15,29 Details on the 
working dilution as well as the staining pattern of these 
antisera in prostate epithelial cells are reported in these 
previous studies.
Tissue Preparation and Antigen Retrieval
Consecutive 4-ju.m-thick sections were cut from the se­
lected blocks, mounted on pretreated slides (Super- 
Frosf/Plus, Menzel-Glaser, Braunschweig, Germany), 
and dried overnight. After dewaxing and rehydration, an 
antigen retrieval step was included. Slides to be stained 
with the antibody 34/3E12 were incubated with 0.1% Pro- 
nase XIV solution (P-5147, Sigma Chemical Co., Diosen- 
hofen, Germany) dissolved in 10 mmol/L Tris, 1 mmol/L 
EDTA, pH 7.5, at 37°C for 10 minutes. For the MAb 
RCK103, antigen retrieval was performed according to a 
modified protocol by submerging the slides in a 0.5% 
periodic acid solution (H5I0 6, Sigma 7875) and micro­
wave heating for two cycles of 5 minutes with power of 
180 W.22 For CK18 (DC 10) and bcl-2,124 microwave heat­
ing with 0.1 mol/L citrate buffer (pH 6.0) was performed 
according to the manufacturer’s instructions.
Materials and Methods
Tissue Specimens
Specimens were selected from 40 formalin-fixed and par- 
affin-embedded blocks of prostate tissue removed from 
22 patients with PCa or BPH (average age, 73.6 ± 16.7 
years) who had not received any hormonal treatment 
before surgery. On sections taken from these blocks a 
standard hematoxylin and eosin staining as well as a 
serotonin immunostaining (see below) were performed. 
Only blocks containing normal secretory giands or nod­
ular BPH and at least 10 serotonin-immunoreactive NE 
cells per field of view (diameter, 0.80 mm) were Included. 
In this way, from 19 patients, 21 tissue blocks were se­
lected. These blocks comprised normal secretory glands 
in 15 and nodular BPH in 10 areas.
Antisera
As NE cell markers we used a rabbit polyclonal antibody 
to serotonin (5-hydroxytryptamine, 5-HT)20 and a mouse 
monoclonal antibody (MAb) to chromogranin A (ChrA; 
Boehringer Mannheim Biochemica, Mannheim, Germa­
ny), To examine the keratin expression by the different 
cell types of prostatic epithelium we used three monoclo­
nal keratin antibodies, ie, 34/3E12 (Dako, Carpinteria, CA) 
recognizing K5 and K14 as a marker for basal cells,27 
RCK103 (MAG, courtesy of Dr. F.C.S. Ramaekers, Maas­
tricht, The Netherlands) recognizing K5 and several other 
keratins in basai cells and intermediate cells (putative 
amplifying cell type),21'"20 and the antibody CK18 (DC- 
10, Dakopatts, Glostrup, Denmark) recognizing K18
Procedure in Detail for Sequential Dual Labeling
Sequential dual labeling was performed for the following 
antibody combinations: 5-HT/34J3E12, 5-HT/RCK103, 5- 
HT/CK18, and 5-HT/bcl-2. After preincubation with 10% 
normal horse serum and 10% norma! goat serum in phos­
phate-buffered saline (PBS), sections were incubated 
with a mixture of one of the mouse MAbs and the rabbit 
polyclonal antiserum to 5-HT at 4°C overnight, after which 
they were rinsed in PBS. Sections were then processed 
with the avidin-biotin complex (ABC) procedure. For de­
tection of the MAbs (34/3E12, CK18, and bcl-2), the sec­
tions were first incubated with rabbit anti-mouse biotiny- 
lated secondary antibodies (1:100). After rinsing with 
PBS they were incubated with a peroxidase-conjugated 
antibody (1:50; Elite Vector ABC kit, PK6100, Vectastain, 
Vector Laboratories, Burlingame, CA). Peroxidase activ­
ity was visualized with diaminobenzidine (DAB) as a 
chromogen. Slides were then rinsed in tap water followed 
by PBS. Subsequently, to detect 5-HT, slides were incu­
bated with goat anti-rabbit biotinylated antibodies for 30 
minutes (1:100), after which they were again rinsed in 
PBS. Finally, they were incubated with an alkaline-phos- 
phatase-conjugated ABC (1:50, Vector ABC kit, AK5000, 
Vectastain) and rinsed in PBS. Immunostaining was visu­
alized with Fast Blue substrate.30 After a final rinse in tap 
water, sections were briefly counterstained in hematoxy­
lin and coverslipped.
For dual staining with the Mab RCK103 and the anti­
body to 5-HT, a modified procedure was followed, be­
cause periodic acid appeared to interfere with the anti- 
gen-antibody binding of 5-HT. After removal of the 
paraffin and rehydration, tissues were first stained with
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Table 1.
Step
Stepwise Procedure to Hvaluale lmtnunoreuctivily in Single Cells by Dual Staining with 5~HT/^48E12, 5-HT/RCK103, 5- 
HT/CK18, or 5-IlT/bcU2
Procedure
1 Sequential dual staining of sections using antisera: 5-HT/34/3E12, 5-HT/RCK103, 5-HT/CK18, or 5 -HT/bcl- 2
2 Selection of areas with normal glands and nodular BPH with high content of NE cells (see Materials and Methods)
3 Photomicrograph of dual staining fields identified in step 2
4 Destaining of slid© in saturated KCI03 solution; selective removal of Fast Bfue deposit (labeling 5-HT)
5 Relocation of NE cel Is in the tissue sections by referring to the photomicrographs taken in step 3
6  Evaluation of the immunoreactivity of cells dual stained with the antibody to 5-HT
7 Documentation of results by taking another photomicrograph of the same location as in step 3 (option)
8  Scoring of the staining patterns of the four MAbs dual stained with 5 -HT, ie, 3 4 /3E1 2 , RCK103, CK18, and bcl-2 , by
counting approximately 100 5-HT-positive NE cells
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5-HT according to the same protocol as described above 
but without an antigen retrieval step. After staining the 
alkaline phosphatase with Fast Blue and rinsing in water, 
slides were treated with periodic acid for keratin antigen 
retrieval. Tissue sections were then incubated with the 
MAb RCK103 after which they were incubated with linker 
antibodies and the ABC (peroxidase labeled) followed by 
staining with DAB.
Evaluation of Immunoreactivity
From each of the 21 paraffin blocks, sets of four consec­
utive sections of 4 /xm were examined for the co-expres­
sion of 5-HT (NE cells) and one of the keratins or bcl-2 by 
removal of the Fast Blue deposit (labeling 5-HT) using 
saturated potassium chlorate (KCI03, see next para­
graph). When no DAB staining was observed we decided 
that no co-expression existed, and intense DAB staining 
was classified as a positive dual staining. The staining 
results were qualified as partial expression when there 
was a dual staining with a weakly and/or focally ex­
pressed DAB label in the cell. Immunoreactivity evalua­
tion was performed in a stepwise procedure for the four 
antibody combinations, ie, 5-HT/34/3E12, 5-HT/RCK103, 
5-HT/CK18, and 5-HT/bcl-2 (for details, see Table 1).
diamond pen on the underside of the slides. Section II 
was dual labeled with a mixture of both antisera (5HT/ 
ChrA) using the procedure we applied to examine the 
co-expression of 5-HT and keratins or bcl-2 as described 
in a previous paragraph, Cells marked in section I as well 
as section III were then relocated in section II. After 
removal of the coverslip, section II was incubated for 1 
hour at room temperature with saturated potassium chlor­
ate solution (2 g of KCI0 3 (Merck 4944) in 700 /xl of 37% 
HCI and 180 ml of 96% ethanol), rinsed with water, de­
hydrated, and again coversllpped.
Identical NE cells could be retrieved in all three num­
bered sections, ie, stained blue (5HT-Fast Blue) in sec­
tion I, dark brown (ChrA-DAB) in section III, and black 
blue in section II (Indicating co-expression for both anti­
bodies), After incubation in the saturated KCIOa solution, 
these cells showed only a brown cytoplasmic staining, 
proving that KCIOa was able to remove the Fast Blue 
staining deposit leaving the DAB staining unaffected.
Scc(i on-I
5HT-Fast B I1 1 0
Validation of the Selective Substrate Deposit 
Removal Procedure
In the literature, several immunoenzymatic cytochemlcal 
procedures are described to detect more than one sub­
stance in a single cell.31 These procedures are based on 
the use of antibodies labeled with different enzymes em­
ploying different chromogens. However, when applied to 
the NE cells of the human prostate the different deposits 
seem to mask each other. Therefore we developed a new 
procedure, depicted in Figure 1, based on the selective 
destaining of one of the deposits.
The validity of this procedure was tested making use of 
the fact that NE cells can be stained by antibodies to 
5-HT and ChrA as well. Three consecutive 4-ju.m tissue 
sections were cut from paraffin blocks and numbered I to 
III. Section I was stained with the antibody to 5-HT using 
Fast Blue as a chromogen. Section III was stained with a 
MAb to ChrA using DAB as a substrate. The position of 
5-HT-positlve cells in section I, also present and Immu- 
noreactive to ChrA in section III, were marked with a
cn
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SHT-Fttst Blue 
ChrA-DAB
Section-Ill
ChrA-DAB
Sectioit-II 
5HT-Frts( Blue 
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Figure 1. Schematic; presentation to Illustrate the development of a positive 
control fur selective substrate* deposit removal. Consecutive sections 
containing prostate NK cells are numbered i to III, Section I was immuno- 
stained with antiserum to 5-HT and Hast Blue as a substrate, Section MI was 
immune «mined with antiserum to ChrA and DAB as a substrate. Section II 
was dual imnumostained with a mixture of antisera to e>-HT/ChrA. Validation 
of the selective substrate deposit removal procedure was based on the 
comparison of section II after KClO  ^ treatment with the staining results 
obtained In sections I and IIL
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Results
NE cells were mostly confined to the basal and supra- 
basal compartments of the epithelium (closed type, Fig­
ure 2A), and some possessed long dendritic processes 
(open type, Figure 2C). Consistent with previous results, 
basal cells were stained positive by 34/3E12, RCK103, 
and the bcl-2 antiserum (Figure 2G), whereas K18 was 
observed only in the luminal cells. In dual-labeled slides 
it was difficult to discern the immunoreactivity of the 
second marker when the KCI03 substrate deposit re­
moval was not applied.
34fiE12 Expression Pattern in NE Cells
After Fast Blue deposit removal in slides stained for 5-HT 
and 34j3E12, only 20% of the NE cells showed a weak 
and focal expression with the basal cell marker. Eighty 
percent of cells were negative, indicating that the majority 
of 5-HT-positive NE cells did not express the basal cell 
keratin marker (compare Figure 2A with 2B).
MAb RCK103 Expression Pattern in NE Cells
Substrate deposit removal of Fast Blue from slides dual 
stained for 5-HT and the MAb RCK103 revealed posftivity 
in 75% of the NE cells, indicating that these cells ex­
pressed the intermediate cell marker as well. Focal ex­
pression of the MAb RCK103 was seen in 18% of NE cells 
whereas 7% of the NE cells did not show the intermediate 
cell keratin phenotype (compare Figure 2C with 2D).
CK18 (DC 10) Expression Pattern In NE Ceils
After removal of the Fast Blue deposit from the dual­
stained sections, the luminal cell marker CK18 was ob­
served in 63% of the NE cells. Weak focal positivity also, 
indicating co-expression of 5-HT and the luminal keratin 
marker, was present in 28% of the NE ceils, and 9% of NE 
cells apparently contained only 5-HT (compare Figure 2E 
with 2F).
Bcl-2 (124) Expression Pattern in NE Cells
All cells that were double stained for 5-HT and bcl-2 were 
negative after deposit removal of Fast Blue, indicating 
that bcl-2 (124) was not expressed in 5-HT-positive NE 
cells in the human prostate (compare Figure 2G with 2H).
The staining results of NE cells are summarized in 
Table 2.
Discussion
In this report we present a number of cell biological 
characteristics of the human prostate NE cells achieved 
by the use of a novel sequentially selective destaining 
immunoenzymatic staining technique. We have applied 
this method to investigate the keratin and bcl-2 expres­
sion by NE cells.
Bcl-2 protein expression has been described in the basal 
cell compartments of various epithelia. The expression of 
bcl-2 by these cells is considered to be indicative for pluri- 
potent stem cells.15 However, knowledge concerning the 
bcl-2 status of NE cells is fragmentary. In some organs, 
such as thyroid, skin, gastrointestinal tract, and lung, these 
cells express the bcl-2 protein whereas NE cells in the 
adrenal gland and pancreas are negative.32,33 In our study, 
NE cells of the human prostate did not show bcl-2 immu­
noreactivity. The absence of bcl-2 staining in those cells 
might be due to the low sensitivity of the detection tech­
nique. However, this is not likely as adjacent basal cells 
were intensely labeled by the same antibody using the 
same procedure. Therefore, we assume that in the human 
prostate NE cells actually are devoid of bcl-2, indicating that 
they are terminally differentiated cells. Several studies sug­
gest that cells containing the bcl-2 protein are protected 
from apoptosis. However, bcl-2 is part of a multigene family 
of proteins involved in protecting cells from apopto- 
sjs 12.13.15 por examp|ei bcl-X, is also found to inhibit apo­
ptosis, but mainly in postmitotic cells with extended survival, 
such as neurons in the brain.34,35 In the human prostate, 
MCL1, another member of bcl-2 gene family, is found only 
in luminal cells, which implies a unique role for this molecule 
in regulation of the survival of differentiated cells.32,36 There­
fore, the absence of bcl-2 in prostate NE cells does not 
exclude the possibility that other member(s) of the bcl-2 
gene family are protecting prostate NE cells from apoptosis.
in cell biological studies on epithelial cells, keratin 
markers are helpful in determining the origin and differ­
ential status of specific epithelial cells in normal tissues 
as well as their malignant counterparts. Using antibodies 
to these keratins, we have previously suggested that 
various types of (exocrine) epithelial cells in the secretory 
acini of the prostate possess a characteristic keratin ex­
pression pattern and seems to be related to cellular 
differentiation and functional status. This pattern is ob­
served in human early prostate development, normal 
adult prostate, BPH, PCa, and rat prostate during involu- 
tion-regeneration processes.20^ 3 Implicit in these obser­
vations is the assumption that there is a lineage relation­
ship between basal and luminal cells via intermediate 
ceils. This relationship has been called the hierarchical 
differential pathway in the stem cell model.2A
To date, investigations in human prostate are mainly 
focused on evaluating the role of NE differentiation in the 
behavior and prognosis of PCa.3 The cell kinetic features 
of NE cells and their interrelationships with other epithelial 
cells in the normal human prostate have not been exten­
sively pursued. In a recent report on the peptidergic 
innervation of the human fetal prostate, NE cells were 
observed as early as 13 weeks gestation.37 However, no 
information concerning their relationships with other exo­
crine cells in terms of glandular morphogenesis and cel­
lular origin were given as epithelial markers were not 
included in this study. Bonkhoff et al reported that some 
NE cells focally express K5 and K14,8 In another study on 
the human prostate tumor cell line LNCaP, modulation of 
a conditioned medium resulted in an increased expres­
sion of luminal keratins in many cells accompanied by the 
appearance of cells with dendritic processes that were
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Table 2 . Imnuinostuining o f Keratins and bcl-2 by 5-H'I -
Positive NE Cells in
34/3E12
RCK103
1lu man Prostate
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In parentheses is the percentage of 5-HT-positive NE cells stained
with one of the antisera to keratins or bcl-2.
SIEIHSEUi .AMPLIFYING CELL,
frequently positive for NE cell markers.38 This observation 
implies that at an early stage of development prostatic 
epithelial cells are pluripotent and capable of differentia­
tion into NE cells. In addition, there is some evidence that 
NE cells have an exocrine function as well.8,39
Our study revealed that a minority of 5-HT-positive NE 
cells contain K5 and K14, keratins expressed by basal 
cells. Many NE cells were stained by the antiserum CK18 
(DC 10) marking luminal epithelial cells as well as the 
antiserum RCK103 predominantly staining the basal cell 
compartment. Our results seem to indicate that in the 
human prostate NE cells represent a heterogeneous pop­
ulation of cells as far as the cytoskeleton pattern is con­
cerned, sharing phenotype characteristics common to 
exocrine cells. Therefore, it is most likely that NE cells are 
derived from the same precursor cells as the exocrine 
prostate cells but not from neural crest cells.7,8 The com­
plexity of the keratin phenotype in NE cells may also 
indicate that their keratin expression pattern does not 
always parallel their functional status. For example, the 
existence of NE cells with low levels of basal cell keratins 
could indicate that these cells have already reached 
terminal differentiation in terms of functional status (eg 1
positive for 5-HT) whereas phenotypically their keratin 
phenotype still carries basal cell characteristics. A com­
parable phenomenon has been observed in the cervical 
epithelium of the uterus 
So far there are only a few reports dealing with the 
proliferative status of NE cells in the human prostate. By
4 0
immunocytochemical methods, Bubendorf et al did not 
find any association between the presence of NE cells 
and Ki67-!abeled tumor cells in the prostate carcinoma
samples studied, Using dual immunoenzymatic labeling 
with antibodies to ChrA and MIB-1, Bonkhoff and co­
authors showed that proliferative activities are restricted 
to only exocrine epithelial cells; ie, NE cells lack MIB-1 
mmunoreactivity.25 NE cells in general may, however, 
undergo some degree of proliferation, as reported in 
rodent models using the bromodeoxyuridine (BrdU) la­
beling method.42,43 So far, there is no information con­
cerning the NE cell proliferative status in human prostate 
tissue using incorporation of radioactive thymidine or the 
thymidine analogue BrdU to identify dividing cells.
Cell proliferation and differentiation are complex biologi­
cal events. Proliferating cells are usually less differentiated, 
and after turnover, these cells gradually acquire differenti­
ation-related functions although not entering the cell cycle
keratin difforontial expression
Figure 3. Prostatic epithelial cells and their interrelationship: a stem cell
m e Horizontal lines indicate basal keratin expression, vertical lines
indicate luminal keratin expression, and crossed lines indicate the transition 
in keratin expression signifying the transition of basal cells to luminal cells via 
intermediate cells (for details see Discussion ).
derived from a functionally less mature cell type and gain 
their NE-related functions afterwards, as proposed in our 
putative stem cell model (Figure 3). As the conventional NE 
markers, such as ChrA and serotonin, are associated with 
secretory functions of NE cells, those with NE potential, but 
not yet fully differentiated, proliferating cells might escape 
identification by these markers. This might explain why 
Noordzij et al could not identify the incorporation of BrdU 
counting 1000 ChrA-positive cells in a human prostate tu­
mor model in mice, although there is an increase in the 
number of NE cells by castration.43 It is suggested by the 
authors that NE differentiation takes place only in cells that 
are in the GO phase. Interestingly, in a recent study by the 
same group, using the same tumor models, a time course 
experiment was performed showing that cells double 
beled for ChrA and BrdU were indeed observed early after 
castration (2 to 4 days) albeit in low numbers.44 Taken 
together, these data indicate that in the human prostate 
epithelium some proliferating cells might exist having NE
differentiation potential. If this is the case, the amplifying 
cells described in our model are most likely the candidates
isfor these not yet fully differentiated NE-potent cells, 
possible that by androgen deprivation a subpopulation of 
these amplifying cells is induced to enter the cell cycle 
followed by differentiation into NE cells. Therefore, NE cells 
in the prostate most likely undergo a similar differential 
pathway parallel to the exocrine cells. By the same token, 
the observations reported by Noordzij et al may also explain 
the high percentage of recurrence in PCa with NE differen­
tiation after androgen ablation. Finally, as luminal cells, 
which are terminally differentiated, regress apoptotically af­
ter androgen withdrawal, it is highly unlikely that NE cells 
originate from them as has been suggested elsewhere.
In conclusion, using a novel sequential destaining im­
munoenzymatic technique we were able to demonstrate 
that the keratin phenotype of NE cells in the human 
prostate overlaps that of exocrine epithelial cells. These 
findings indicate that NE cells and other prostate epithe­
lial cells in the human prostate share a common keratin
1 1
again. It is therefore possible that prostate NE cells are phenotype and probably originate from a common epi
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thelial precursor. From the absence of bcl-2 we infer that 
the NE cells have no progenitor cell characteristics.
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